Yasuo Takashima

1.3k total citations
45 papers, 1.0k citations indexed

About

Yasuo Takashima is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Yasuo Takashima has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Neurology and 10 papers in Cancer Research. Recurrent topics in Yasuo Takashima's work include CNS Lymphoma Diagnosis and Treatment (11 papers), Glioma Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Yasuo Takashima is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (11 papers), Glioma Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Yasuo Takashima collaborates with scholars based in Japan, United States and Finland. Yasuo Takashima's co-authors include Ryuya Yamanaka, Azusa Hayano, Atsushi Suzuki, Atsushi Kawaguchi, Senji Shirasawa, Toshiyuki Tsunoda, Takehiko Sasazuki, Keiko Doi, Midori Koyanagi and Takahiro Fujimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.

In The Last Decade

Yasuo Takashima

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuo Takashima Japan 24 447 228 206 178 157 45 1.0k
Elspeth M. Beauchamp United States 18 1.1k 2.5× 288 1.3× 150 0.7× 141 0.8× 88 0.6× 32 1.5k
Tommaso Zanocco‐Marani Italy 18 543 1.2× 141 0.6× 135 0.7× 96 0.5× 129 0.8× 38 890
Donatella Malanga Italy 20 731 1.6× 433 1.9× 290 1.4× 45 0.3× 92 0.6× 45 1.3k
Wenwu Zhai United States 16 543 1.2× 120 0.5× 90 0.4× 76 0.4× 159 1.0× 19 1.3k
Kacper Jankowski United States 12 714 1.6× 534 2.3× 188 0.9× 133 0.7× 65 0.4× 15 1.4k
Shalini C. Reshmi United States 20 1.1k 2.4× 268 1.2× 312 1.5× 159 0.9× 242 1.5× 54 1.8k
Defen Shen United States 32 774 1.7× 359 1.6× 129 0.6× 117 0.7× 379 2.4× 74 2.4k
Luís A. Corchete Spain 22 820 1.8× 488 2.1× 294 1.4× 125 0.7× 31 0.2× 78 1.5k
Majid Shahbazi Iran 13 463 1.0× 271 1.2× 161 0.8× 58 0.3× 28 0.2× 72 1.1k
Hiroyasu Inada Japan 18 773 1.7× 167 0.7× 167 0.8× 46 0.3× 155 1.0× 30 1.5k

Countries citing papers authored by Yasuo Takashima

Since Specialization
Citations

This map shows the geographic impact of Yasuo Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Takashima more than expected).

Fields of papers citing papers by Yasuo Takashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Takashima. The network helps show where Yasuo Takashima may publish in the future.

Co-authorship network of co-authors of Yasuo Takashima

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Takashima. A scholar is included among the top collaborators of Yasuo Takashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Takashima. Yasuo Takashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinoshita, Mao, Tasuku Matsuyama, Kunihiko Kooguchi, et al.. (2024). Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure. Critical Care. 28(1). 134–134. 1 indexed citations
2.
Takashima, Yasuo, Kengo Yoshii, Azusa Hayano, et al.. (2023). Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. International Journal of Clinical Oncology. 28(3). 468–481. 9 indexed citations
3.
Takashima, Yasuo, Atsushi Kawaguchi, Junya Fukai, et al.. (2021). Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma. PLoS ONE. 16(6). e0251272–e0251272. 11 indexed citations
4.
Takashima, Yasuo, Azusa Hayano, & Ryuya Yamanaka. (2020). Metabolome analysis reveals excessive glycolysis via PI3K/AKT/mTOR and RAS/MAPK signaling in methotrexate-resistant primary CNS lymphoma-derived cells. Clinical Cancer Research. 26(11). clincanres.3851.2018–clincanres.3851.2018. 35 indexed citations
5.
Takashima, Yasuo, Junya Fukai, Yasuo Iwadate, et al.. (2020). GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL. Scientific Reports. 10(1). 8435–8435. 10 indexed citations
6.
Takashima, Yasuo, Atsushi Kawaguchi, Yasuo Iwadate, et al.. (2019). MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PLoS ONE. 14(1). e0210400–e0210400. 24 indexed citations
7.
Takashima, Yasuo, Atsushi Kawaguchi, Azusa Hayano, & Ryuya Yamanaka. (2019). CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme. PLoS ONE. 14(5). e0216825–e0216825. 31 indexed citations
8.
Takashima, Yasuo, Atsushi Kawaguchi, Ryuichi Sato, et al.. (2019). Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL. Scientific Reports. 9(1). 10004–10004. 29 indexed citations
9.
Hayano, Azusa, Yasuo Takashima, & Ryuya Yamanaka. (2019). Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells. International Journal of Clinical Oncology. 24(9). 1020–1029. 10 indexed citations
10.
Yamanaka, Ryuya, Azusa Hayano, & Yasuo Takashima. (2017). Trilateral retinoblastoma: A systematic review of 211 cases. Neurosurgical Review. 42(1). 39–48. 19 indexed citations
11.
Horisawa, Kenichi, et al.. (2016). Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma. Scientific Reports. 6(1). 34691–34691. 24 indexed citations
12.
Takashima, Yasuo & Atsushi Suzuki. (2013). Regulation of organogenesis and stem cell properties by T-box transcription factors. Cellular and Molecular Life Sciences. 70(20). 3929–3945. 28 indexed citations
13.
Doi, Keiko, Takahiro Fujimoto, Midori Koyanagi, et al.. (2011). ZFAT is a critical molecule for cell survival in mouse embryonic fibroblasts. Cellular & Molecular Biology Letters. 16(1). 89–100. 15 indexed citations
14.
Matsumoto‐Nakano, Michiyo, Kazuyo Fujita, Shigenori Inagaki, et al.. (2011). Inhibitory Effects of Oenothera biennis (Evening Primrose) Seed Extract on Streptococcus mutans and S. mutans-Induced Dental Caries in Rats. Caries Research. 45(1). 56–63. 22 indexed citations
15.
Yoshida, Yasuhiro, Toshiyuki Tsunoda, Keiko Doi, et al.. (2011). KRAS-mediated up-regulation of RRM2 expression is essential for the proliferation of colorectal cancer cell lines.. PubMed. 31(7). 2535–9. 34 indexed citations
16.
Tsunoda, Toshiyuki, Yasuo Takashima, Yasuhiro Yoshida, et al.. (2011). Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.. PubMed. 31(7). 2453–9. 37 indexed citations
17.
Fujita, Kazuyo, Yasuo Takashima, Shigenori Inagaki, et al.. (2010). Correlation of biological properties with glucan-binding protein B expression profile in Streptococcus mutans clinical isolates. Archives of Oral Biology. 56(3). 258–263. 5 indexed citations
18.
Fujimoto, Takahiro, Keiko Doi, Midori Koyanagi, et al.. (2009). ZFAT is an antiapoptotic molecule and critical for cell survival in MOLT‐4 cells. FEBS Letters. 583(3). 568–572. 37 indexed citations
19.
Tsunoda, Toshiyuki, Bungo Furusato, Yasuo Takashima, et al.. (2009). The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma. The Prostate. 69(13). 1398–1403. 52 indexed citations
20.
Bando, Tetsuya, et al.. (2007). Tissue-specific interactions of TNI isoforms with other TN subunits and tropomyosins in C. elegans: The role of the C- and N-terminal extensions. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(4). 456–465. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elspeth M. Beauchamp Breakdown of academic impact, for papers by Tommaso Zanocco‐Marani Breakdown of academic impact, for papers by Donatella Malanga Breakdown of academic impact, for papers by Wenwu Zhai Breakdown of academic impact, for papers by Kacper Jankowski Breakdown of academic impact, for papers by Shalini C. Reshmi Breakdown of academic impact, for papers by Defen Shen Breakdown of academic impact, for papers by Luís A. Corchete Breakdown of academic impact, for papers by Majid Shahbazi Breakdown of academic impact, for papers by Hiroyasu Inada
Rankless by CCL
2026